Best General Drug Manufacturer Stocks to Buy Now (2026)Top general drug manufacturer stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 9th ranked industry out of 146 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | $1.07T | $72.25B | $33.17B | $25.28B | $28.19 | 47.44% | 23.17% | 128.44% | 33.25% | 2026-08-05 | ||
| BMY | BRISTOL MYERS SQUIBB CO | $116.95B | $48.48B | $13.19B | $7.28B | $3.57 | 1.78% | 2.52% | 33.21% | N/A | 2026-07-30 | ||
| ABBV | ABBVIE INC | $401.47B | $62.82B | $16.65B | $3.64B | $2.03 | 9.50% | 4.59% | -13.98% | -6.16% | 2026-07-30 | ||
| AZN | ASTRAZENECA PLC | $288.04B | $60.44B | $20.46B | $10.39B | $6.71 | 9.93% | 16.99% | 33.93% | 17.16% | |||
| BIIB | BIOGEN INC | $28.84B | $9.94B | $2.43B | $1.37B | $9.35 | 1.23% | -4.64% | -7.97% | -13.53% | 2026-07-30 | ||
| MRK | MERCK & CO INC | $298.33B | $65.77B | $19.40B | $8.94B | $3.57 | 2.89% | 9.46% | -48.19% | 5.13% | 2026-08-04 | ||
| SNY | SANOFI | $109.80B | $55.61B | $17.97B | $9.30B | $3.81 | 19.14% | 3.82% | 62.78% | -8.84% | 2026-07-30 | ||
| PFE | PFIZER INC | $148.41B | $63.32B | $14.46B | $7.49B | $1.31 | 1.36% | 6.56% | -5.76% | -7.26% | 2026-07-29 | ||
| JNJ | JOHNSON & JOHNSON | $560.33B | $96.36B | $33.71B | $21.04B | $8.73 | 7.87% | 2.73% | -3.64% | 8.75% | 2026-07-15 | ||
| GRFS | GRIFOLS SA | $5.25B | $8.75B | $1.85B | $467.44M | $0.69 | 17.83% | 6.33% | 189.17% | -8.77% | 2026-07-29 | ||
| AMRN | AMARIN CORP PLC | $292.10M | $216.76M | -$27.75M | -$33.61M | -$1.60 | 1.24% | -18.46% | N/A | N/A | 2026-07-29 | ||
| GSK | GSK PLC | $103.63B | $44.30B | $9.81B | $7.88B | $3.91 | 6.74% | 7.06% | 92.03% | 1.30% | 2026-07-28 | ||
| AMGN | AMGEN INC | $188.67B | $37.22B | $16.67B | $7.80B | $14.48 | 9.07% | 8.14% | 31.04% | 3.55% | 2026-08-04 | ||
| GILD | GILEAD SCIENCES INC | $160.36B | $29.74B | $14.49B | $9.22B | $7.42 | 3.48% | 3.07% | 55.56% | 97.01% | 2026-08-06 | ||
| NVS | NOVARTIS AG | $284.61B | $56.58B | $28.03B | $13.53B | $7.02 | 6.31% | 2.55% | 9.18% | 14.87% | 2026-07-21 | ||
| SCLX | SCILEX HOLDING CO | $59.44M | $33.86M | -$359.15M | -$419.68M | -$40.47 | -33.22% | N/A | N/A | N/A | |||
| OGN | ORGANON & CO | $3.51B | $6.16B | $1.39B | $246.00M | $0.94 | -2.08% | -0.31% | -67.70% | -33.69% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $42.02M | $0.00 | -$9.81M | -$31.37M | -$1.27 | N/A | N/A | N/A | N/A | |||
| NSRX | NASUS PHARMA LTD | $26.42M | $0.00 | -$5.92M | -$5.86M | -$0.72 | N/A | N/A | N/A | N/A | |||
| MDCX | MEDICUS PHARMA LTD | $19.83M | $0.00 | -$38.92M | -$51.22M | -$2.69 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.